CPT code 42160 designates destruction of a lesion on the palate or uvula using methods such as laser or cryotherapy. This procedure is relevant across otolaryngology and oral surgery practices where localized oropharyngeal lesions require ablative treatment. Nationally, proper coding of this service affects clinical documentation, setting-appropriate billing, and consistency in reporting procedural care for oropharyngeal lesions.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage considerations, common procedure settings, and coding context that influence reimbursement and claim adjudication. It provides benchmarks where available, notes policy trends that affect authorization and site-of-service determinations, and situates the procedure within typical clinical workflows for lesion management.

Readers will learn: the clinical scope of CPT code 42160, typical sites of service for delivery, how major payers approach coverage and prior authorization, and where documentation should focus to support medical necessity. Data not available in the input is identified when applicable.